Sensenig Bethany

CIK 00018999353 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001899935

Recent Transactions

18 trades

Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-19−4,475→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-19$51.27/sh−3,258→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-19$50.31/sh−1,217→ 3,258 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-19+4,475→ 4,475 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2026-02-18+4,977→ 4,977 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-18+2,989→ 2,989 total
Award
KalVista Pharmaceuticals, Inc.$KALV
Stock Option (right to buy)
2025-10-01+45,000→ 45,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-14$42.25/sh−5,369→ 0 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2025-02-22−5,369→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+5,369→ 5,369 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,475→ 4,475 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2025-02-19+7,296→ 7,296 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2024-02-22+5,369→ 5,369 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2024-02-22+8,252→ 8,252 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2023-08-17+24,153→ 24,153 total
Sale
9 METERS BIOPHARMA, INC.
Common stock
2023-04-21$1.21/sh−9,100→ 41,077 total
Award
9 METERS BIOPHARMA, INC.
Common Stock
2023-03-27+50,177→ 50,177 total
Award
9 METERS BIOPHARMA, INC.
Stock Option (Right to Buy)
2022-01-18+1,300,000→ 1,300,000 total

Companies

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov